Michael Saccente

1.7k total citations
26 papers, 1.1k citations indexed

About

Michael Saccente is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Michael Saccente has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 15 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Michael Saccente's work include Antifungal resistance and susceptibility (10 papers), Fungal Infections and Studies (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Michael Saccente is often cited by papers focused on Antifungal resistance and susceptibility (10 papers), Fungal Infections and Studies (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Michael Saccente collaborates with scholars based in United States. Michael Saccente's co-authors include Gail L. Woods, Peter G. Pappas, Carol A. Kauffman, David W. Haas, Robert A. Larsen, Gretchen A. Cloud, Richard J. Hamill, William E. Dismukes, Robin M. Warren and Harold Henderson and has published in prestigious journals such as Clinical Microbiology Reviews, Clinical Infectious Diseases and Clinical Orthopaedics and Related Research.

In The Last Decade

Michael Saccente

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Saccente United States 11 874 844 141 105 58 26 1.1k
Yolanda Meije Spain 19 761 0.9× 669 0.8× 222 1.6× 34 0.3× 70 1.2× 34 1.1k
Dimitra Mitsani United States 11 592 0.7× 571 0.7× 156 1.1× 34 0.3× 80 1.4× 11 810
Lisa Brumble United States 16 521 0.6× 470 0.6× 147 1.0× 56 0.5× 44 0.8× 55 791
Patricia Mariani France 11 311 0.4× 334 0.4× 116 0.8× 83 0.8× 26 0.4× 21 642
Eddie Louie United States 12 621 0.7× 467 0.6× 120 0.9× 28 0.3× 47 0.8× 25 908
Émilie Catherinot France 17 1.1k 1.2× 817 1.0× 127 0.9× 433 4.1× 22 0.4× 37 1.4k
R.P. Hobson United Kingdom 14 402 0.5× 449 0.5× 45 0.3× 51 0.5× 120 2.1× 19 867
S.C.-A. Chen Australia 10 528 0.6× 792 0.9× 56 0.4× 81 0.8× 28 0.5× 10 960
Paul McWhinney United Kingdom 15 439 0.5× 337 0.4× 44 0.3× 69 0.7× 117 2.0× 27 748
A. Safdar United States 11 343 0.4× 342 0.4× 59 0.4× 63 0.6× 136 2.3× 16 704

Countries citing papers authored by Michael Saccente

Since Specialization
Citations

This map shows the geographic impact of Michael Saccente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Saccente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Saccente more than expected).

Fields of papers citing papers by Michael Saccente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Saccente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Saccente. The network helps show where Michael Saccente may publish in the future.

Co-authorship network of co-authors of Michael Saccente

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Saccente. A scholar is included among the top collaborators of Michael Saccente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Saccente. Michael Saccente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fisher, John F., et al.. (2025). Chronic Cavitary Pulmonary Histoplasmosis–Novel Concepts Regarding Pathogenesis. Journal of Fungi. 11(3). 201–201.
2.
3.
Baddley, John W., Joshua Wolf, Monica I. Ardura, et al.. (2025). 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas) in Adults, Children, and Pregnant People. Clinical Infectious Diseases. 81(Supplement_3). i33–i38. 1 indexed citations
4.
Lentz, Robert J., Kayla R. Stover, Nathan P. Wiederhold, et al.. (2025). 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People. Clinical Infectious Diseases. 81(Supplement_3). i39–i45. 3 indexed citations
5.
Patil, Nirav, et al.. (2010). A clinical review of Lyme disease in Arkansas.. PubMed. 106(8). 186–8. 1 indexed citations
6.
Atiq, Muslim, et al.. (2009). Isolated tuberculosis of the pancreas: a case report.. PubMed. 10(1). 64–6. 8 indexed citations
7.
Gubbins, Paul O., Bill J. Gurley, David Williams, et al.. (2008). Examining sex-related differences in enteric itraconazole metabolism in healthy adults using grapefruit juice. European Journal of Clinical Pharmacology. 64(3). 293–301. 10 indexed citations
8.
Bariola, J Ryan & Michael Saccente. (2008). Candida lusitaniae septic arthritis: case report and review of the literature. Diagnostic Microbiology and Infectious Disease. 61(1). 61–63. 10 indexed citations
9.
Saccente, Michael. (2008). Central nervous system histoplasmosis. Current Treatment Options in Neurology. 10(3). 161–167. 42 indexed citations
10.
Saccente, Michael. (2006). Mycobacterium fortuitum group periprosthetic joint infection. Scandinavian Journal of Infectious Diseases. 38(8). 737–739. 11 indexed citations
11.
Gubbins, Paul O., Scott A. McConnell, Bill J. Gurley, et al.. (2004). Influence of Grapefruit Juice on the Systemic Availability of Itraconazole Oral Solution in Healthy Adult Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(4). 460–467. 23 indexed citations
12.
Saccente, Michael, et al.. (2003). Cerebral Histoplasmosis in the Azole Era: Report of Four Cases and Review. Southern Medical Journal. 96(4). 410–416. 21 indexed citations
13.
Nelson, Carl L., et al.. (2002). Detecting Bacterial Colonization of Implanted Orthopaedic Devices by Ultrasonication. Clinical Orthopaedics and Related Research. 403(403). 29–37. 62 indexed citations
14.
Pappas, Peter G., John R. Perfect, Gretchen A. Cloud, et al.. (2001). Cryptococcosis in Human Immunodeficiency Virus–Negative Patients in the Era of Effective Azole Therapy. Clinical Infectious Diseases. 33(5). 690–699. 451 indexed citations
15.
Penzak, Scott, et al.. (1999). Grapefruit Juice Decreases the Systemic Availability of Itraconazole Capsules in Healthy Volunteers. Therapeutic Drug Monitoring. 21(3). 304–304. 38 indexed citations
16.
Saccente, Michael. (1999). Klebsiella pneumoniae Liver Abscess, Endophthalmitis, and Meningitis in a Man with Newly Recognized Diabetes Mellitus. Clinical Infectious Diseases. 29(6). 1570–1571. 71 indexed citations
17.
Saccente, Michael, Robert S. Abernathy, Peter G. Pappas, H R Shah, & Robert W. Bradsher. (1998). Vertebral Blastomycosis with Paravertebral Abscess: Report of Eight Cases and Review of the Literature. Clinical Infectious Diseases. 26(2). 413–418. 45 indexed citations
18.
Saccente, Michael. (1998). Periprosthetic Joint Infections. Infectious Diseases in Clinical Practice. 7(9). 431–441. 9 indexed citations
19.
Broker, Thomas R., M. Richardson, K. Squires, et al.. (1998). MOLECULAR EPIDEMIOLOGY OF HPV INFECTIONS OF THE FEMALE GENITAL TRACT, IDENTIFIED BY A NOVEL PCR/RESTRICTION/SEQUENCING ANALYSIS OF RENAL TRANSPLANT CANDIDATES & RECIPIENTS AND OF HIV-POSITIVE PATIENTS.. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). A13–A13. 1 indexed citations
20.
Saccente, Michael & C. Glenn Cobbs. (1996). CLINICAL APPROACH TO INFECTIVE ENDOCARDITIS. Cardiology Clinics. 14(3). 351–362. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yolanda Meije Breakdown of academic impact, for papers by Dimitra Mitsani Breakdown of academic impact, for papers by Lisa Brumble Breakdown of academic impact, for papers by Patricia Mariani Breakdown of academic impact, for papers by Eddie Louie Breakdown of academic impact, for papers by Émilie Catherinot Breakdown of academic impact, for papers by R.P. Hobson Breakdown of academic impact, for papers by S.C.-A. Chen Breakdown of academic impact, for papers by Paul McWhinney Breakdown of academic impact, for papers by A. Safdar
Rankless by CCL
2026